-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Invivo Therapeutics Holdings Corp. quarterly/annual Depreciation history and growth rate from Q2 2011 to Q3 2023.
- Invivo Therapeutics Holdings Corp. Depreciation for the quarter ending September 30, 2023 was $4K, a 71.4% decline year-over-year.
- Invivo Therapeutics Holdings Corp. Depreciation for the twelve months ending September 30, 2023 was $53K, a 8.16% increase year-over-year.
- Invivo Therapeutics Holdings Corp. annual Depreciation for 2022 was $60K, a 71.4% increase from 2021.
- Invivo Therapeutics Holdings Corp. annual Depreciation for 2021 was $35K, a 20.7% increase from 2020.
- Invivo Therapeutics Holdings Corp. annual Depreciation for 2020 was $29K, a 25.6% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)